{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-011178","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.549341+00:00","generated_at":"2026-06-17T08:11:50.422061+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tivic Health FY2022 revenue $1.8M (+46% YoY); cash $3.5M, no debt","bullets":["Revenue $1.8M (+46% YoY); direct-to-consumer sales $1.6M (+114%).","Gross profit $299K vs gross loss of $38K in 2021; 9X gross margin improvement.","Operating expenses: R&D $1.7M, S&M $2.8M, G&A $5.9M (total $10.4M).","Cash $3.5M, no debt; used for operations and attempted acquisition of Reliefband.","CEO cites supply chain challenges but expects growth in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-011178","json":"https://secwatch.observer/filing/0000950170-23-011178.json","markdown":"https://secwatch.observer/filing/0000950170-23-011178.md","text":"https://secwatch.observer/filing/0000950170-23-011178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023011178/0000950170-23-011178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023011178/tivc-20230331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:11:50.422061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"491a396b6811fa489c3294ec9900272266819df0","claim":"Valion Bio, Inc. reported the year ending December 31, 2022 results: revenue $1.8 million.","evidence_excerpt":"increased $583 thousand (46%) to $1.8 million for the year ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023011178/0000950170-23-011178-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ending December 31, 2022"},{"label":"Revenue","value":"$1.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}